• Login as Editor
    View Item 
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    •   Yeshiva Academic Institutional Repository
    • Albert Einstein College of Medicine (AECOM)
    • Albert Einstein College of Medicine: Doctoral Dissertations
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Utilizing adenoviral E3 immunomodulatory genes for prevention of hepatocellular allograft rejection

    Thumbnail
    Date
    2006
    Author
    Mashalova, Elena Vassileva
    Metadata
    Show full item record
    Abstract
    Hepatocyte transplantation is being explored as a life-saving treatment for patients with inherited liver diseases and liver failure. However, allograft rejection remains a major obstacle. Availability of genetically modified liver cells capable of evading immune rejection could obviate the need for long-term immunosuppression with its associated untoward side effects. Gene products of the early region-3 (AdE3) of the adenoviral genome are known to protect infected cells from immune recognition and destruction. Here we show that when immortalized rat hepatocytes are stably transduced with AdE3 and transplanted into the spleen or liver of fully MHC-mismatched rats, these cells are protected from allograft rejection. Quantitative real-time PCR analysis showed that a similar number of engrafted AdE3-transfected hepatocytes had survived in syngeneic and allogeneic recipients. Immunofluorescence studies revealed the presence of clusters of the transplanted allogeneic hepatocytes, demonstrating AdE3-mediated immunoprotection, as well as preferential proliferation of the engrafted hepatocytes. Cell surface expression of MHC class I on the donor hepatocytes was not reduced by AdE3 expression. Consistent with this, in vivo CTL alloresponse was attenuated, but not abolished in recipients of AdE3-transfected allogeneic hepatocytes. In contrast, AdE3 gene expression resulted in marked reduction of cell surface localization of Fas. Furthermore, expression of AdE3 genes in the donor hepatocytes inhibited TNF-alpha-induced degradation of IkappaB-alpha and phosphorylation of c-Jun, indicating inhibition of NF-kappaB and JNK/AP-1 pathways. Thus, the principle mechanism by which AdE3 gene products prevent allograft rejection appears to be related to the anti-apoptotic and anti-inflammatory functions of these proteins. Our results provide a rational for using the AdE3 genes as a target-specific immunomodulatory tool for facilitating allogeneic hepatocyte transplantation.
    Permanent Link(s)
    https://yulib002.mc.yu.edu/login?url=http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&res_dat=xri:pqm&rft_dat=xri:pqdiss:3222578
    https://hdl.handle.net/20.500.12202/861
    Collections
    • Albert Einstein College of Medicine: Doctoral Dissertations [1674]

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University
     

     

    Browse

    AllCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    Login as Editor

    Statistics

    View Usage Statistics

    Yeshiva University Libraries copyright © 2021  DuraSpace
    YAIR Self-Deposit | YAIR User's Guide | Take Down Policy | Contact Us
    Yeshiva University